Source: https://edoc.mdc-berlin.de/view/journals/European_Journal_of_Heart_Failure.html
Timestamp: 2019-04-20 08:49:03+00:00

Document:
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines.
Zamorano, J.L. and Lancellotti, P. and Rodriguez Muñoz, D. and Aboyans, V. and Asteggiano, R. and Galderisi, M. and Habib, G. and Lenihan, D.J. and Lip, G.Y.H. and Lyon, A.R. and Lopez Fernandez, T. and Mohty, D. and Piepoli, M.F. and Tamargo, J. and Torbicki, A. and Suter, T.M. and Zamorano, J.L. and Aboyans, V. and Achenbach, S. and Agewall, S. and Badimon, L. and Barón-Esquivias, G. and Baumgartner, H. and Bax, J.J. and Bueno, H. and Carerj, S. and Dean, V. and Erol, C. and Fitzsimons, D. and Gaemperli, O. and Kirchhof, P. and Kolh, P. and Lancellotti, P. and Lip, G.Y.H. and Nihoyannopoulos, P. and Piepoli, M.F. and Ponikowski, P. and Roffi, M. and Torbicki, A. and Vaz Carneiro, A. and Windecker, S.
Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
Scherbakov, N. and Bauer, M. and Sandek, A. and Szabo, T. and Toepper, A. and Jankowska, E.A. and Springer, J. and von Haehling, S. and Anker, S.D. and Lainscak, M. and Engeli, S. and Duengen, H.D. and Doehner, W.
Increased catabolic activity in adipose tissue of patients with chronic heart failure.
Szabo, T. and Postrach, E. and Maehler, A. and Kung, T. and Turhan, G. and Von Haehling, S. and Anker, S.D. and Boschmann, M. and Doehner, W.
Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.
van Rijsingen, I.A.W. and Nannenberg, E.A. and Arbustini, E. and Elliott, P.M. and Mogensen, J. and Hermans-van Ast, J.F. and van der Kooi, A.J. and van Tintelen, J.P. and van den Berg, M.P. and Grasso, M. and Serio, A. and Jenkins, S. and Rowland, C. and Richard, P. and Wilde, A.A.M. and Perrot, A. and Pankuweit, S. and Zwinderman, A.H. and Charron, P. and Christiaans, I. and Pinto, Y.M.
Long-term benefits of immunoadsorption in beta(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
Dandel, M. and Wallukat, G. and Englert, A. and Lehmkuhl, H.B. and Knosalla, C. and Hetzer, R.
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart Failure.
Waldmueller, S. and Erdmann, J. and Binner, P. and Gelbrich, G. and Pankuweit, S. and Geier, C. and Timmermann, B. and Haremza, J. and Perrot, A. and Scheer, S. and Wachter, R. and Schulze-Waltrup, N. and Dermintzoglou, A. and Schoenberger, J. and Zeh, W. and Jurmann, B. and Brodherr, T. and Boergel, J. and Farr, M. and Milting, H. and Blankenfeldt, W. and Reinhardt, R. and Oezcelik, C. and Osterziel, K.J. and Loeffler, M. and Maisch, B. and Regitz-Zagrosek, V. and Schunkert, H. and Scheffold, T.
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.
Duengen, H.D. and Apostolovic, S. and Inkrot, S. and Tahirovic, E. and Toepper, A. and Mehrhof, F. and Prettin, C. and Putnikovic, B. and Neskovic, A.N. and Krotin, M. and Sakac, D. and Lainscak, M. and Edelmann, F. and Wachter, R. and Rau, T. and Eschenhagen, T. and Doehner, W. and Anker, S.D. and Waagstein, F. and Herrmann-Lingen, C. and Gelbrich, G. and Dietz, R.
Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF).
Stockburger, M. and Gomez-Doblas, J.J. and Lamas, G. and Alzueta, J. and Fernandez-Lozano, I. and Cobo, E. and Wiegand, U. and Concha, J.F. and Navarro, X. and Navarro-Lopez, F. and de Teresa, E.
A pilot study of chronic, low-dose epoetin-β following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure.
Bergmann, M.W. and Haufe, S. and von Knobelsdorff-Brenkenhoff, F. and Mehling, H. and Wassmuth, R. and Muench, I. and Busjahn, A. and Schulz-Menger, J. and Jordan, J. and Luft, F.C. and Dietz, R.
el Azzouzi, H. and van Oort, R.J. and van der Nagel, R. and Sluiter, W. and Bergmann, M.W. and De Windt, L.J.
Indication for bromocriptine in peripartum cardiomyopathy: reply.
Habedank, D. and Haverkamp, W. and Dudenhausen, J.W. and Dietz, R.
Heart transplantation in heart failure: The prognostic importance of body mass index at time of surgery and subsequent weight changes.
Clark, A.L. and Knosalla, C. and Birks, E. and Loebe, M. and Davos, C.H. and Tsang, S. and Negassa, A. and Yacoub, M. and Hetzer, R. and Coats, A.J.S. and Anker, S.D.
Inhibition of prolyl 4-hydroxylase prevents left ventricular remodelling in rats with thoracic aortic banding.
Fielitz, J. and Philipp, S. and Herda, L.R. and Schuch, E. and Pilz, B. and Schubert, C. and Gunzler, V. and Willenbrock, R. and Regitz-Zagrosek, V.
Is there a common genetic basis for all familial cardiomyopathies?
Perrot, A. and Dietz, R. and Osterziel, K.J.
Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: Demand for strategies in the management of presymptomatic lamin A/C mutant carriers.
Perrot, A. and Sigusch, H.H. and Naegele, H. and Genschel, J. and Lehmkuhl, H. and Hetzer, R. and Geier, C. and Perez, L.V. and Reinhard, D. and Dietz, R. and Osterziel, K.J. and Schmidt, H.H.
Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats.
Philipp, S. and Juergensen, J.S. and Fielitz, J. and Bernhardt, W.M. and Weidemann, A. and Schiche, A. and Pilz, B. and Dietz, R. and Regitz-Zagrosek, V. and Eckardt, K.U. and Willenbrock, R.
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice.
McMurray, J. and Cohen-Solal, A. and Dietz, R. and Eichhorn, E. and Erhardt, L. and Hobbs, F.D. and Krum, H. and Maggioni, A. and McKelvie, R.S. and Pina, I.L. and Soler-Soler, J. and Swedberg, K.
Studies on intragastric PCO2 at rest and during exercise as a marker of intestinal perfusion in patients with chronic heart failure.
Krack, A. and Richartz, B.M. and Gastmann, A. and Greim, K. and Lotze, U. and Anker, S.D. and Figulla, H.R.
Regulation of caspase 3 and Fas in pressure overload-induced left ventricular dysfunction.
Philipp, S. and Pagel, I. and Hoehnel, K. and Lutz, J. and Buttgereit, J. and Langenickel, T. and Hamet, P. and Dietz, R. and Willenbrock, R.
Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice.
McMurray, J. and Cohen-Solal, A. and Dietz, R. and Eichhorn, E. and Erhardt, L. and Hobbs, R. and Maggioni, A. and Pina, I. and Soler-Soler, J. and Swedberg, K.
A new model of congestive heart failure in the mouse due to chronic volume overload.
Scheuermann-Freestone, M. and Freestone, N.S. and Langenickel, T. and Hoehnel, K. and Dietz, R. and Willenbrock, R.
The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe.
Cleland, J.G.F. and Swedberg, K. and Cohen-Solal, A. and Cosin-Aguilar, J. and Dietz, R. and Follath, F. and Gavazzi, A. and Hobbs, R. and Korewicki, J. and Madeira, H.C. and Preda, I. and van Gilst, W.H. and Widimsky, J. and Mareev, V. and Mason, J. and Freemantle, N. and Eastaugh, J.
This list was generated on Sat Apr 20 02:36:29 2019 CEST.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V.

 V. 
 V.